The use of semirigid rod penile prosthesis for the management of erectile dysfunction was first described over 85 years ago. Since then, there have been numerous design advancements leading to improved overall durability, concealability, rigidity, and natural feel. However, the inflatable penile prosthesis (IPP) still has a higher patient satisfaction rate and is currently the most commonly inserted prostheses in the United States. There are still certain situations and conditions where the simplicity of a rod may be preferred over an IPP. A pair of semirigid rods has been shown to have less risk of malfunction and need for revision surgery. In addition, patients with poor manual dexterity, those undergoing a salvage for infection prosthesis and those with a prolonged (> 48 h) priapic episode may be better served with a rod than an IPP. Finally, in patients compromised by infection or priapism, the rods can later successfully be exchanged for an IPP with potentially longer, wider cylinders with resultant greater patient satisfaction.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
International Journal of Impotence Research Open Access 17 January 2023
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54–61.
Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200:633–41.
Gee WF. A history of surgical treatment of impotence. Urology. 1975;05:401–5.
Goodwin WE, Scott WW. Phalloplasty. J Urol. 1952;68:903–8.
Beheri GE. Surgical treatment of impotence. Plast Reconstr Surg. 1966;38:92–7.
Pearman RO. Treatment of organic impotence by implantation of a penile prosthesis. J Urol. 1967;97:716–9.
Small MP, Carrion HM, Gordon JA. Small-Carrion penile prosthesis. New implant for management of impotence. Urology. 1975;5:479–86.
Henry GD. Historical review of penile prosthesis design and surgical techniques: part 1 of a three-part review series on penile prosthetic surgery. J Sex Med. 2009;6:675–81.
Sadeghi-Nejad H. Penile prosthesis surgery: a review of prosthetic devices and associated complications. J Sex Med. 2007;4:296–309.
Subrini L. A biomechanical study of flexible penile implants. Ann Urol. 1993;27:192–6.
Ferguson KH, Cespedes RD. Prospective long-term results and quality-of-life assessment after Dura-II penile prosthesis placement. Urology. 2003;61:437–41.
Eland IA, van der Lei J, Stricker BH, Sturkenboom MJ. Incidence of priapism in the general population. Urology. 2001;57:970–2.
Kohler TS, Wen L, Wilson SK. Penile implant infection prevention part 1: what is fact and what is fiction? Int J Impot Res. 2020. https://doi.org/10.1038/s41443-o20-0326-5.
Stein DM, Flum AS, Cashy J, Zhao LC, McVary KT. Nationwide emergency department visits for priapism in the United States. J Sex Med. 2013;10:2418–22.
Tausch TJ, Zhao LC, Morey AF, Siegel JA, Belsante MJ, Seideman CA, et al. Malleable penile prosthesis is a cost-effective treatment for refractory ischemic priapism. J Sex Med. 2015;12:824–6.
Ralph DJ, Garaffa G, Muneer A, Freeman A, Rees R, Christopher AN, et al. The immediate insertion of a penile prosthesis for acute ischaemic priapism. Eur Urol. 2009;56:1033–8.
Zacharakis E, Garaffa G, Raheem AA, Christopher AN, Muneer A, Ralph DJ. Penile prosthesis insertion in patients with refractory ischaemic priapism: early vs delayed implantation. BJU Int. 2014;114:576–81.
Sedigh O, Rolle L, Negro CL, Ceruti C, Timpano M, Galletto E, et al. Early insertion of inflatable prosthesis for intractable ischemic priapism: our experience and review of the literature. Int J Impot Res. 2011;23:158–64.
Zacharakis E, De Luca F, Raheem AA, Garaffa G, Christopher N, Muneer A;etal. Early insertion of a malleable penile prosthesis in ischaemic priapism allows later upsizing of the cylinders. Scand J Urol. 2015;49:468–71.
Brant MD, Ludlow JK, Mulcahy JJ. The prosthesis salvage operation: immediate replacement of the infected penile prosthesis. J Urol. 1996;155:155–7.
Mulcahy JJ. Long-term experience with salvage of infected penile implants. J Urol. 2000;163:481–2.
Pineda M, Burnett AL. Penile prosthesis infections-a review of risk factors, prevention, and treatment. Sex Med Rev. 2016;4:389–98.
Kohler TS, Modder JK, Dupree JM, Bush NC, McVary KT. Malleable implant substitution for the management of penile prosthesis pump erosion: a pilot study. J Sex Med. 2009;6:1474–8.
Gross MS, Phillips EA, Balen A, Eid JF, Yang C, Simon R, et al. The malleable implant salvage technique: infection outcomes after mulcahy salvage procedure and replacement of infected inflatable penile prosthesis with malleable prosthesis. J Urol. 2016;195:694–7.
Habous M, Tealab A, Farag M, Soliman T, Williamson B, Mahmoud S, et al. Malleable penile implant is an effective therapeutic option in men with peyronie’s disease and erectile dysfunction. Sex Med. 2018;6:24–29.
Ghanem HM, Fahmy I, el-Meliegy A. Malleable penile implants without plaque surgery in the treatment of Peyronie’s disease. Int J Impot Res. 1998;10:171–3.
Montorsi F, Guazzoni G, Bergamaschi F, Rigatti P. Patient-partner satisfaction with semirigid penile prostheses for Peyronie’s disease: a 5-year followup study. J Urol. 1993;150:1819–21.
Kim YD, Yang SO, Lee JK, Jung TY, Shim HB. Usefulness of a malleable penile prosthesis in patients with a spinal cord injury. Int J Urol. 2008;15:919–23.27.
Zermann DH, Kutzenberger J, Sauerwein D, Schubert J, Loeffler U. Penile prosthetic surgery in neurologically impaired patients: long-term followup. J Urol. 2006;175(3 Pt 1):1041–4. discussion 1044.
Lacy JM, Walker J, Gupta S, Davenport DL, Preston DM. Risk factors for removal or revision of penile prostheses in the veteran population. Urology. 2016;98:189–94.
Minervini A, Ralph DJ, Pryor JP. Outcome of penile prosthesis implantation for treating erectile dysfunction: experience with 504 procedures. BJU Int. 2006;97:129–33.
Casabe AR, Sarotto N, Gutierrez C, Bechara AJ. Satisfaction assessment with malleable prosthetic implant of Spectra (AMS) and Genesis (Coloplast) models. Int J Impot Res. 2016;28:228–33.
Conflict of interest
MK: Consultant Boston Scientific. JM: Consultant Boston Scientific, Coloplast. LW: none. SW: Consultant Coloplast, International Medical Devices. Lecturer Boston Scientific Stockholder NeoTract
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Khera, M., Mulcahy, J., Wen, L. et al. Is there still a place for malleable penile implants in the United States? Wilson’s Workshop #18. Int J Impot Res 35, 82–89 (2023). https://doi.org/10.1038/s41443-020-00376-6
This article is cited by
International Journal of Impotence Research (2023)
International Journal of Impotence Research (2023)